NIH-funded research R01 grant

Investigating how risedronate can prevent bone loss after bariatric surgery

Official title: Adding bone microarchitecture and strength measures to the STRONG BONES randomized trial examining risedronate use to mitigate bone loss after bariatric surgery

Funded at Wake Forest University Health Sciences · NIH-11038003 · Data updated 2026-11-12

This study is looking at whether the medication risedronate can help prevent bone loss in people over 40 who have had sleeve gastrectomy for weight loss, and it will involve 120 participants taking either the medication or a placebo for six months.

More Bariatric Surgery research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startFebruary 23, 2024
Project endJanuary 31, 2028
Funding year2025
Award (this year)$380,865
NIH project number5R01AR083706-02
Project IDNIH-11038003 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 40 and older who have recently undergone sleeve gastrectomy.

Less likely to help

Patients who have not had bariatric surgery or are younger than 40 may not benefit from this research.

What this research studies

This research focuses on patients who have undergone bariatric surgery, specifically sleeve gastrectomy, which can lead to bone loss. It aims to determine if the medication risedronate, typically used for osteoporosis, can help mitigate this bone loss. The study will involve 120 participants aged 40 and older, who will be randomly assigned to receive either risedronate or a placebo for six months. Researchers will use advanced imaging techniques to assess changes in bone microarchitecture and strength over time.

Why it matters

Potential benefit: If successful, this research could help prevent bone fragility in patients who have undergone bariatric surgery, improving their overall health and quality of life.

How similar studies have gone: Previous studies have shown that bisphosphonates can be effective in preventing bone loss in various populations, suggesting potential success for this approach in bariatric surgery patients.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Weaver, Ashley — Wake Forest University Health Sciences
  • Study coordinator: Weaver, Ashley

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.